The cancer has one of the lowest survival rates, with fewer than 5% of patients surviving five or more years after diagnosis. The idea is to deliver oxygen to the tumour and improve radiotherapy treatments.
The treatment will not be available for a number of years. Survival rates had not improved in 40 years, said Prof John Callan, who is leading the Ulster University research. Read more . . .